The page is the record's research on the issuer — no analyst, no rating, no view.

Ajanta Pharma Limited (INE031B01049) — research page

IN · in-cm-kg/XNSE/INE031B01049 · as of 2026-11-06

Identity and listing

The issuer is Ajanta Pharma Limited, listed on the National Stock Exchange of India under ticker INE031B01049, with ISIN INE031B01049. The LEI is not on the record. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.

fieldvaluesource · read date
nameAjanta Pharma Limitedsource · 2026-11-06
exchangeNational Stock Exchange of Indiasource · 2026-11-06
tickerINE031B01049source · 2026-11-06
ISININE031B01049source · 2026-11-06
LEInot on the record
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 0 filings in the window 2025-11-06 to 2026-11-06, across 0 filing days. The median gap between filing days is not on the record, and no latest filing date or latest filing type is on the record. The exchange peer set holds 2613 issuers, with a median cadence gap not on the record, a median of 0 filings, and a median latency not on the record. Sector peer figures are not on the record for this market.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer0——
exchange median: National Stock Exchange of India (2613 issuers)0nullnull

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes, so no changes are given.

Events and halts

The lifecycle lines for listing, delisting, name change, domicile change and segment move are not on the record, because the index does not carry a lifecycle type for this market. The halt flag shows listed, not halted.

Orderability

The rule version is acm-68000/in/sebi-suitability-sebi-investment-advisers-regulations-2013-r/r1, with the chapter as of 2026-11-04. The outcome is ACM-200 and determinable for each of the four client categories: accredited investor, Retail individual investor, Qualified Institutional Buyer, and Non-Institutional Investors.

client categoryoutcome
Non‐Institutional InvestorsACM-200
Qualified Institutional BuyerACM-200
Retail individual investorACM-200
accredited investorACM-200

rule acm-68000/in/sebi-suitability-sebi-investment-advisers-regulations-2013-r/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page, so the count is 0.

Open research

No openly published research notes were found, so the count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage of this market is not sealed. No issuer years are sealed, and the market earliest sealed date and the live record start date are not on the record.

Sources

5 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://nsearchives.nseindia.com/content/equities/EQUITY_L.csv (identity.exchange)
10.2
https://mcp.in-cm-kg.ai/events/XNSE/INE031B01049 (the disclosure lines)
10.3
https://www.nseindia.com/regulations/listing-compliance (the halt flag)
10.4
https://mcp.in-cm-kg.ai/book/aio.json (the orderability chapter)
10.5
https://mcp.in-cm-kg.ai/record/XNSE/INE031B01049 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"INE031B01049"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:0e7073ea65b1b4bf.